Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Life Sciences to Create New US Headquarters

Published: Wednesday, August 20, 2014
Last Updated: Thursday, August 21, 2014
Bookmark and Share
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.

GE Healthcare Life Sciences announced today that it will open a new 160,000 square-foot facility in Marlborough, Massachusetts, as the new headquarters for its US operations. A $21M investment in the long-term future of this key GE Healthcare growth business, it will establish a new site for more than 500 GE Healthcare Life Sciences employees, including the creation of more than 220 new jobs in the US's leading life sciences and biotechnology cluster. Recruitment has begun with the site scheduled to open in Spring 2015, offering a dynamic working environment and career opportunities with a global leader in technology, science and business innovation.

“Our new facility in Massachusetts will position us for continued innovation and competition in such a fast-paced, innovative industry,” said Kieran Murphy, President and CEO of GE Healthcare Life Sciences. “We will be close to industry-leading talent, customers, and world-class academic and medical institutions across all the industry sectors we serve, from biotech and pharma, to diagnostics and medical devices.”

“Today, Massachusetts’ life sciences sectors are the fastest-growing sectors of our economy. We look forward to welcoming the U.S. life sciences headquarters of GE Healthcare and are pleased that the company will create a substantial number of new, STEM-related job opportunities in central Massachusetts,” said Governor Deval Patrick.

This investment will transform a currently unoccupied space into state-of-the-art labs, customer application facilities, and office space to complement GE Healthcare Life Sciences’ existing manufacturing capability in Westborough, Mass. The facility will consolidate GE Healthcare Life Sciences’ US East Coast presence, bringing together a critical mass of talent and expertise-dedicated collaboration, innovation and leadership in the industry. When fully operational, the new facility will bring more than 220 highly qualified new job opportunities to the area, including highly skilled positions such as lab technicians, biologists, medical doctors, process engineers, and customer service representatives.

GE Healthcare Life Sciences’ $4B business has more than 11,500 employees in over 100 countries, with the mission of enabling a new era of molecular and precision medicine. By providing customers with tools, insight and knowledge, GE Healthcare helps them accelerate the journey from biological understanding to clinical therapy. The new US headquarters will house employees from across the Life Sciences business, including its research, bioprocessing, medical imaging, in vitro diagnostics and services segments.

“Marlborough continues to be a center for innovation. This GE Healthcare Life Sciences investment, adding more than 220 new jobs with an exciting biotechnology leader, is proof that innovation is thriving outside Route 128, and of Marlborough’s ability to build the necessary infrastructure to attract top-tier, global life sciences companies,” said Mayor Arthur Vigeant.

“MassBIO continues to be engaged in policy, economic development and STEM education to foster the world’s leading biotech cluster. We are excited to continue work with industry leaders like GE Healthcare Life Sciences to promote innovation in the Greater Marlborough area,” said Robert Coughlin, President, MassBIO.

GE Healthcare Life Sciences has been actively supporting the development of new therapies for more than 60 years, with innovative technologies, services and solutions that enable the research, development, manufacture and use of the next generation of therapies. With technologies along the entire drug development, production and clinical continuum, GE helps scientists and physicians answer critical questions at every stage, from early research to patient diagnosis in the clinic.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences Strengthens Business Resilience with ISO 22301
$100 million investment to double manufacturing capacity for chromatography media by 2018.
Saturday, December 05, 2015
GE Healthcare Life Sciences and Emerson Team Up
Collaboration will help drive improvements in productivity.
Saturday, November 28, 2015
GE Healthcare Life Sciences to Open Biopharmaceutical Technology and Training Laboratory in Turkey
Supports Turkey’s ambitions to expand domestic biopharmaceutical industry. Laboratory will be a key component of GE’s new Innovation Center in Istanbul.
Friday, November 14, 2014
GE Healthcare Life Sciences Named as Finalist for Four Bioprocess Industry Awards
Awards celebrate and recognize the outstanding people, organizations and technologies.
Saturday, October 04, 2014
GE Healthcare Appoints Emmanuel Ligner as General Manager
Emmanuel will oversee all worldwide commercial activities of Company's rapidly growing BioProcess business.
Friday, April 11, 2014
GE, NetBio to Validate Fully Integrated Rapid DNA system
Verification by forensic laboratories is a key step toward responsible adoption for crime laboratory and in-the-field law enforcement use.
Friday, March 21, 2014
Spectacular Images Showing Research into Cancer, Neurodegenerative Disease and Fertility
Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore announced as the winners of the GE Healthcare 2013 Cell Imaging Competition.
Wednesday, March 12, 2014
GE Healthcare to Build KUBio Factory for JHL Biotech in China
New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia.
Thursday, September 26, 2013
GE Healthcare Life Sciences and Osaka University Team Up
Top four graduate students to be hosted at GE Healthcare Life Science’s Uppsala site.
Wednesday, August 21, 2013
GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc.
Acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of recombinant proteins, antibodies and vaccines.
Tuesday, May 15, 2012
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Apricot Kernels Pose Risk of Cyanide Poisoning
Eating more than three small raw apricot kernels, or less than half of one large kernel, in a serving can exceed safe levels. Toddlers consuming even one small apricot kernel risk being over the safe level.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
A lncRNA Regulates Repair of DNA Breaks in Breast Cancer Cells
Findings give "new insight" into biology of tough-to-treat breast cancer.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!